Naranjo's MDA, harmaline and ibogaine therapy (historical)

Domain VII · Transpersonal, psychedelic & altered states · Claudio Naranjo · 1962 · Chile

What it is

HISTORICAL — NOT FOR USE. This entry describes a historical drug-assisted psychotherapy as history. It gives no doses, routes, schedules or administration details, and nothing here should be read as a protocol. MDA, harmaline and ibogaine are not approved medicines for psychotherapy; this guide…

Format

• This is not a phased therapy with a manual. No published phase model, standard number of sessions, or criteria for moving between phases is available for Naranjo's MDA, MMDA, harmaline or ibogaine work. Catalogue and review pages show that the book is organised by substance, not by phase, and is…
• Session format. Six MDA sessions: four with single participants and two with married couples. Each was closely observed throughout the drug effect, with a sympathetic observer available; otherwise the session was largely unstructured.

Who practises it, and how they are trained or regulated

• Legal and regulatory status (as of the sources' dates). MDA: Schedule I in the US, Class A in the UK, and in Schedule I of the UN 1971 Convention on Psychotropic Substances; also prohibited in Canada (Schedule I), Australia (S9), Germany (Anlage I, authorised scientific use only) and across the EU. Harmaline and harmine: uncontrolled federally in the US (supplement, food and drug law still applies); controlled in…
• Framework for a clinician today. One to three assessment and integration sessions, inside ordinary psychotherapy, when a client (a) took part in historical or underground sessions with these substances, (b) cites Naranjo or The Healing Journey to justify a practice they are considering or have been offered, or (c) plans to use ibogaine or ayahuasca-type preparations outside a regulated setting. Goals: safety…

Questions to explore with your client

• What drew you to it, and what are you hoping it will change?
• Is there physical contact? Was it explained beforehand, and do you feel free to say no or stop at any point?
• Does it involve any substance, plant preparation, remedy or supplement? Has your doctor or prescriber been told, especially about any medication you take?
• Is it a group, retreat or community? How do they respond if someone wants to leave or raises a concern?
• How do you and the practitioner understand what is happening, in spiritual or cultural terms? Is that a source of comfort, worry, or both?
• Who runs it, and what training or registration do they hold?
• What actually happens in a session or meeting, and how often?
• What does it cost, and is there pressure to commit to more?
• How do you feel afterwards, in the hours and days that follow?
• Does it fit with, or clash with, the work we do here?

What practitioners of it watch for

• Plans that involve stopping prescribed medication on someone else's advice, being alone, being far from emergency care, or using it to self-treat addiction.
• Shame or secrecy, and missing memory for parts of the sessions (temporary amnesia was documented with MDA). Also watch for persisting distress tied to imagery.
• Marketing that uses "pioneer" lineage, "fantasy-enhancer" or "emotion-enhancer" language, or a Gestalt or Enneagram pedigree to imply safety. Look for an absence of medical screening.

When to involve someone else

• New or worsening physical symptoms, or advice to stop or change prescribed medication: involve the client's doctor or prescriber.
• Signs of coercion, isolation from family and friends, escalating costs or secrecy: discuss openly and consider safeguarding.
• A crisis or thoughts of suicide: follow your crisis protocol. In the US, call or text 988; in the UK and Ireland, Samaritans on 116 123.

Drawn automatically from the guide's own sections. Stay curious: neither endorse nor dismiss what the client values, and check anything that matters against the full guide and its sources. Not medical advice.